title: Aberrant DNA methylation associated with silencing BNIP3 gene expression in haematopoietic tumours.
abstract: Hypoxia is a key factor contributing to the progression of human neoplasias and to the development of resistance to chemotherapy. BNIP3 is a proapoptotic member of the Bcl-2 protein family involved in hypoxia-induced cell death. We evaluated the expression and methylation status of BNIP3 gene to better understand the role of epigenetic alteration of its expression in haematopoietic tumours. Methylation of the region around the BNIP3 transcription start site was detected in four acute lymphocytic leukaemia, one multiple myeloma and one Burkitt lymphoma cell lines, and was closely associated with silencing the gene. That expression of BNIP3 was restored by treatment with 5-aza2'-deoxycytidine (5-aza-dC), a methyltransferase inhibitor, which confirmed the gene to be epigenetically inactivated by methylation. Notably, re-expression of BNIP3 using 5-aza2-dC also restored hypoxia-mediated cell death in methylated cell lines. Acetylation of histone H3 in the 5' region of the gene, which was assessed using chromatin immunoprecipitation assays, correlated directly with gene expression and inversely with DNA methylation. Among primary tumours, methylation of BNIP3 was detected in five of 34 (15%) acute lymphocytic leukaemias, six of 35 (17%) acute myelogenous leukaemias and three of 14 (21%) multiple myelomas. These results suggest that aberrant DNA methylation of the 5' CpG island and histone deacetylation play key roles in silencing BNIP3 expression in haematopoietic tumours.
authors.affiliation: First Department of Internal Medicine, Sapporo Medical University, Sapporo 060-8556, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Murai
authors.forename: M
authors.initials: M
authors.lastname: Toyota
authors.forename: A
authors.initials: A
authors.lastname: Satoh
authors.forename: H
authors.initials: H
authors.lastname: Suzuki
authors.forename: K
authors.initials: K
authors.lastname: Akino
authors.forename: H
authors.initials: H
authors.lastname: Mita
authors.forename: Y
authors.initials: Y
authors.lastname: Sasaki
authors.forename: T
authors.initials: T
authors.lastname: Ishida
authors.forename: L
authors.initials: L
authors.lastname: Shen
authors.forename: G
authors.initials: G
authors.lastname: Garcia-Manero
authors.forename: J-P J
authors.initials: JP
authors.lastname: Issa
authors.forename: Y
authors.initials: Y
authors.lastname: Hinoda
authors.forename: T
authors.initials: T
authors.lastname: Tokino
authors.forename: K
authors.initials: K
authors.lastname: Imai
mesh_terms: D001483:Base Sequence; D045744:Cell Line, Tumor; D018899:CpG Islands; D019175:DNA Methylation; D020868:Gene Silencing; D019337:Hematologic Neoplasms / Q000235:genetics*; D006801:Humans; D008565:Membrane Proteins / Q000235:genetics*; D008969:Molecular Sequence Data; D011518:Proto-Oncogene Proteins / Q000235:genetics*
chemical_list: C090121:BNIP3 protein, human; D008565:Membrane Proteins; D011518:Proto-Oncogene Proteins